Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
ICCT 
iCoreConnect Inc. Common stock (ICCT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: ICCT (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
AI Based Fundamental Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Analysis of Past Performance
Type Stock | Historic Profit 521.38% | Avg. Invested days 44 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 9.78M USD | Price to earnings Ratio - | 1Y Target Price 0.5 |
Price to earnings Ratio - | 1Y Target Price 0.5 | ||
Volume (30-day avg) 22145130 | Beta 1.08 | 52 Weeks Range 0.24 - 35.80 | Updated Date 04/1/2025 |
52 Weeks Range 0.24 - 35.80 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -63.2 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -263.11% | Operating Margin (TTM) -78.92% |
Management Effectiveness
Return on Assets (TTM) -69.89% | Return on Equity (TTM) -1718.32% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 21551450 | Price to Sales(TTM) 0.89 |
Enterprise Value 21551450 | Price to Sales(TTM) 0.89 | ||
Enterprise Value to Revenue 1.95 | Enterprise Value to EBITDA -7.48 | Shares Outstanding 2073020 | Shares Floating 1073263 |
Shares Outstanding 2073020 | Shares Floating 1073263 | ||
Percent Insiders 10.61 | Percent Institutions 3.23 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
iCoreConnect Inc. Common stock
Company Overview
History and Background
iCoreConnect, Inc. was founded in 2013. It aims to leverage cloud-based technology for healthcare professionals. Since its IPO, the company has been focused on expanding its product offerings and customer base in the healthcare sector.
Core Business Areas
- Dental Software: Provides practice management, electronic health records (EHR), and patient communication solutions for dental practices.
- Medical Software: Offers similar solutions tailored for medical practices, including EHR, billing, and telehealth capabilities.
- Compliance Solutions: Delivers HIPAA-compliant email and security tools to protect patient data and ensure regulatory compliance.
Leadership and Structure
iCoreConnect is led by a team of executives with experience in healthcare technology. The organizational structure is designed to support product development, sales, and customer support.
Top Products and Market Share
Key Offerings
- iCoreDental: A comprehensive dental practice management software. Market share data is limited due to the fragmented nature of the market. Competitors include Dentrix, Eaglesoft, and Open Dental. Information regarding revenue is unavailable.
- iCoreMD: A medical practice management and EHR software. Market share data is limited. Competitors include athenahealth, Epic Systems, and Cerner. Information regarding revenue is unavailable.
- iCoreExchange: Secure, HIPAA-compliant email communication and data sharing. Market share is not available. Competitors include Microsoft 365, Google Workspace. Information regarding revenue is unavailable.
Market Dynamics
Industry Overview
The healthcare technology industry is experiencing significant growth, driven by the increasing adoption of EHRs, telehealth, and other digital health solutions. Regulatory requirements and the need for improved patient care are also contributing to the growth.
Positioning
iCoreConnect is positioned as a provider of integrated solutions for small to medium-sized healthcare practices. Its competitive advantage lies in its user-friendly interface and its focus on compliance.
Total Addressable Market (TAM)
The global healthcare IT market is projected to reach hundreds of billions of dollars. iCoreConnect's positioning in the SMB segment allows it to target a significant portion of this TAM.
Upturn SWOT Analysis
Strengths
- Integrated platform
- HIPAA compliance
- User-friendly interface
- Focus on SMBs
Weaknesses
- Limited market share compared to larger competitors
- Financial resources
- Scalability challenges
- Brand recognition
Opportunities
- Increasing demand for telehealth solutions
- Expansion into new healthcare specialties
- Strategic partnerships with other healthcare providers
- Growing regulatory requirements for data security
Threats
- Competition from established players
- Rapid technological advancements
- Changes in healthcare regulations
- Economic downturns
Competitors and Market Share
Key Competitors
- athenahealth (ATHA)
- NextGen Healthcare (NXGN)
- Cerner (ORCL)
- Henry Schein One (HSIC)
Competitive Landscape
iCoreConnect faces strong competition from larger, more established players. Its success depends on its ability to differentiate itself through its integrated platform and focus on SMBs.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends require analysis of past financial performance.
Future Projections: Future projections require consulting analyst reports.
Recent Initiatives: Recent initiatives require reviewing press releases and investor presentations.
Summary
iCoreConnect is a relatively young company in the competitive healthcare technology market. Its integrated platform and focus on SMBs are strengths, but it faces challenges from larger competitors. The company needs to continue to innovate and expand its customer base to achieve sustainable growth and profitability. Monitoring market trends and regulatory changes is crucial for mitigating potential threats.
Similar Companies
ATHA
Athira Pharma Inc
ATHA
Athira Pharma Inc
HSIC
Henry Schein Inc
HSIC
Henry Schein Inc
ORCL
Oracle Corporation
ORCL
Oracle Corporation
Sources and Disclaimers
Data Sources:
- Company Website
- Public Filings
- Industry Reports
- Analyst Reports (where available)
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share data is approximate and may vary depending on the source. Financial data should be verified through official company filings. This analysis is based on publicly available information and subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About iCoreConnect Inc. Common stock
Exchange NASDAQ | Headquaters Ocoee, FL, United States | ||
IPO Launch date 2022-04-19 | President, CEO & Chairman Mr. Robert P. McDermott | ||
Sector Healthcare | Industry Health Information Services | Full time employees 67 | Website https://www.icoreconnect.com |
Full time employees 67 | Website https://www.icoreconnect.com | ||
iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.